CERP >>Announces Algaeplast(TM), Inc
Cereplast to Channel All Its Breakthrough Algae Activity in a New Subsidiary
EL SEGUNDO, Calif., Feb. 20, 2013 (GLOBE NEWSWIRE) -- Cereplast, Inc. (CERP) (the "Company"), a leading manufacturer of proprietary biobased, compostable and sustainable bioplastics, today announced the incorporation of a new wholly owned subsidiary, Algaeplast(TM), Inc. Algaeplast' s focus will be the development and manufacture of algae-based bioplastics. Cereplast has been a pioneer in algae-based plastics, helping to bring the first products made from Cereplast Algae Bioplastics(TM) grades to market in 2011, and with the recent commercialization of Biopropylene(R) 109D in December of 2012.
Cereplast introduced the concept in late 2009, with a target of reaching a bioplastic made from 50% algae bio-content. Algaeplast's ultimate goal is to bring to market new polymers made from 100% algae content. Recently, the Company commercialized small quantities of Biopropylene 109D, a compound with 20% post-industrial algae biomatter. The research and development team is currently developing a grade with a higher percentage of algae bio-content. Based on customer interest, the Company has determined that the demand for bioplastics made from algae is significant, and therefore has created Algaeplast, which will focus on this new sector. Algaeplast has been created to develop a new monomer and polymers made from algae.
Mr. Frederic Scheer, Chairman and CEO of Cereplast, stated, "With recent developments made in the algae-to-oil process, the company believes it will reach its goal within less than 5 years, either solely or in partnership with other significant players in the field."
Recently, Cereplast announced that it uses a post-industrial process that significantly reduces the odor that is normally inherent to algae biomatter, eliminating customer concerns about working with the material. Additionally, the Company uses algae biomass byproducts from algae biofuels and nutritionals that do not rely on the commercialization of biofuel production. These advancements fostered the commercialization of the Cereplast Algae Bioplastics product line earlier than expected.
Mr. Scheer added, "We began developing algae-based bioplastics in 2008, have made several breakthroughs since, and are very close to reaching our original goal of 50% algae bio-content. We continue to receive a lot of interest in this material for a variety of applications and are committed to further developing this new category of plastic. We foresee significant revenue potential. The next frontier for Algaeplast is to generate new polymers that are made with 100% algae bio-content, and based on our current level of knowledge, we anticipate reaching that goal within the next five years. The first milestone will be to increase the level of algae bio-content from 20% post-industrial algae biomatter to 50%, and this next step is imminent. Achieving these goals will require additional research, development and partnerships, and we have a very clear understanding of what needs to be done to reach this goal. As such, we felt that it was important to segregate this activity from the development of our starch-based bioplastic grades, and create Algaeplast."
About Cereplast, Inc.
Cereplast, Inc. (CERP) designs and manufactures proprietary biobased, sustainable bioplastics which are used as substitutes for traditional plastics in all major converting processes - such as injection molding, thermoforming, blow molding and extrusions - at a pricing structure that is competitive with traditional plastics. On the cutting-edge of biobased plastic material development, Cereplast now offers resins to meet a variety of customer demands. Cereplast Compostables(R) resins are ideally suited for single-use applications where high biobased content and compostability are advantageous, especially in the food service industry. Cereplast Sustainables(R) resins combine high biobased content with the durability and endurance of traditional plastic, making them ideal for applications in industries such as automotive, consumer electronics and packaging. Learn more at www.cereplast.com. You may also visit the Cereplast social networking pages at Facebook.com/Cereplast, Twitter.com/Cereplast and Youtube.com/Cereplastinc.
The Cereplast, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=9567
Safe Harbor Statement
Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, the impact on the national and local economies resulting from terrorist actions, and U.S. actions subsequently; and other factors detailed in reports filed by the Company.
Contact:
Cereplast, Inc.
Public Relations
Nicole Robertson
(310) 615-1900 x154
nrobertson@cereplast.com
Investor Relations:
Alliance Advisors, LLC
Alan Sheinwald
914-669-0222
asheinwald@allianceadvisors.net
Valter Pinto
914-669-0222 x201
valter@allianceadvisors.net
www.AllianceAdvisors.net
Posted On: 03/05/2013 2:24:18 PM
Post# of 144096
(0)
(0)
Top 10 Most Recent Blog Posts
Windtree's Latest Advances: Istaroxime Clinical Trials
Category: Stocks Total Views: 105
By : Lucas Young Updated: 07-28-2024
Windtree Therapeutics Updates Istaroxime Clinical Development and Trial Data
Providing a thorough update on the clinical and business development of istaroxime, Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company committed to developing creative therapies for critical diseases, has This first-in-class treatment seeks to raise blood pressure, preserve or increase renal function, and strengthen systolic contraction and diastolic relaxation of the heart. In three Phase 2 trials... Continue Reading
SEC Charges Citron Capital in Multi-Year Fraud Scheme
Category: Investing Total Views: 70
By : Evelyn Baker Updated: 07-28-2024
SEC Charges Andrew Left and Citron Capital in $20 Million Fraud Scheme
Andrew Left and his company, Citron Capital LLC, have been charged with a $20 million fraud by the Securities and Exchange Commission (SEC). They are activists short sellers. The SEC complaint claims Left recommended stock positions using his Citron Research website and social media platform. He said these positions complemented Citron Capital's and his own investments. Left's recommendations, according to the SEC,... Continue Reading
BurgerFi Resolves Lawsuit, Plans Strategic Expansion
Category: Stocks Total Views: 120
By : Owen Jenkins Updated: 07-28-2024
BurgerFi International Settles Litigation with Lion Point Capital
The owner of Anthony's Coal Fired Pizza & Wings and BurgerFi brand, BurgerFi International, Inc. (NASDAQ: BFI, BFIIW), revealed a sizable settlement with Lion Point Capital, LP. This agreement settles all outstanding claims brought by Lion Point against BurgerFi since the litigation started.
BurgerFi will pay Lion Point $1,350,000 in installments per terms of the settlement. BurgerFi will also issue Lion Point 300,00... Continue Reading
Market Volatility Ahead of Fed Meeting and Jobs Data
Category: Markets Total Views: 97
By : Logan Wright Updated: 07-28-2024
Upcoming Earnings Reports from Tech Giants
The earnings reports from some of the most well-known tech companies—including Microsoft, Apple, Amazon, and Meta Platforms—are much awaited by investors. These studies are vital since they might either calm the market or cause more volatility. A rally in tech stocks stalled in the second half of July, which caused a notable selloff following Tesla and Alphabet's underperformance. The results this week will be a litmus test for the ma... Continue Reading
Trump Supports Crypto with New Bitcoin Reserve Plan
Category: Crypto Total Views: 233
By : Dylan Bailey Updated: 07-27-2024
Trump Champions U.S. Bitcoin Reserve at Bitcoin Conference
At the Bitcoin Conference in Nashville, former US President Donald Trump declared his endorsement of a strategic national bitcoin reserve. He underlined the need to keep the government's seized bitcoin intact and never sell it. This action seeks to confirm his ranking as the preferred candidate for the crypto community. With his audacious crypto policies, Trump's speech drew in over 3,000 people. The announcement fits the increa... Continue Reading
Weak Demand and Global Issues Impact China's Industries
Category: Economy Total Views: 205
By : Olivia Taylor Updated: 07-27-2024
China's Industrial Profits Accelerate in June
China's industrial gains in June increased more quickly, a reflection of good economic trends despite underlying problems. Official figures revealed a 3.6% year-on-year rise in profits, against a 0.7% increase in May. Strong industry output, according to the National Bureau of Statistics (NBS), helped to explain this increase. Since the second quarter also had a major influence, the easing of factory-gate price declines also reflects. This... Continue Reading
Key Tech Earnings to Shape Market's Near-Term Trajectory
Category: Markets Total Views: 188
By : Thomas Cooper Updated: 07-27-2024
Anticipation Builds for Major Tech Earnings
Earnings reports from big tech companies are much awaited by investors, who might shape the direction of American stock markets. Next week Microsoft, Apple, Amazon, and Meta Platforms have to report their quarterly results. The tech industry has shown notable volatility; recent results from Alphabet and Tesla let down the market. This begs questions regarding whether other tech behemoths can satisfy great expectations. These firms' performance i... Continue Reading
Essential Guide to Bonds: Investing for Beginners
Category: Investing Total Views: 176
By : Kelly Martin Updated: 07-27-2024
Understanding the Basics of Bonds
Bonds are debt instruments companies use to generate capital. Bonds are bought by investors, so the issuing body lends funds. The issuer promises to pay interest at regular intervals in exchange, then return the principal amount on the maturity date. For bondholders, this procedure produces a consistent income source. Bonds can help to lower general volatility and diversify a portfolio. These are often considered safer investments than stocks. Still, knowledg... Continue Reading
Improving Inflation Data Boosts Global Market Sentiment
Category: Economy Total Views: 210
By : Ryan Hughes Updated: 07-27-2024
Global Stocks Rebound After Four-Day Decline
Friday's global stocks show a notable comeback, the first increase in four sessions. Following a dramatic selloff, this recovery found equities stable among bettering economic signals. Data showing a small rise in the personal consumption expenditures (PCE) price index were published by the Commerce Department. Last month this index—a Federal Reserve preferred inflation gauge—rose 0.1%. The statistics implied a possible relaxation o... Continue Reading
OpenAI Launches SearchGPT: A Game Changer in AI Search
Category: Business Total Views: 366
By : Henry Turner Updated: 07-26-2024
OpenAI Unveils SearchGPT: A New Era in Search Technology
Recently OpenAI revealed a prototype of its own search engine, SearchGPT. This instrument seeks to give users quick, accurate responses backed by pertinent, clear sources. Under alpha testing with a small group of users, SearchGPT promises to transform online information search. This tool is meant to be included into the viral chatbot ChatGPT so that a more natural and simple search experience is enabled. Like in a conversation, users w... Continue Reading